
Mettler-Toledo International MTD
$ 1 152.81
2.1%
Quarterly report 2026-Q1
added 05-08-2026
Mettler-Toledo International EV/EBITDA Ratio 2011-2026 | MTD
Annual EV/EBITDA Ratio Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 627 | 659 | 595 | 797 | 827 | 16.4 | 25.9 | 23 | 27.8 | 20.5 | 17.2 | 18 | 16.4 | 15.4 | 14.9 | 162 | 117 | 120 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 827 | 14.9 | 228 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
2.04 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
-0.68 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 201.42 | -0.84 % | $ 22.4 B | ||
|
Celcuity
CELC
|
-32.4 | $ 87.16 | -1.57 % | $ 4.08 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 4.0 | -6.76 % | $ 5.32 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 20.83 | 0.63 % | $ 604 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 18.67 | -0.05 % | $ 575 M | ||
|
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-38.2 | $ 131.64 | 0.02 % | $ 16.5 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 23.44 | 2.02 % | $ 1.25 B | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
20 | $ 146.34 | 0.11 % | $ 11.5 B | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.64 | 2.19 % | $ 7.26 M | ||
|
Illumina
ILMN
|
22.1 | $ 165.6 | 2.88 % | $ 25.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 104.33 | -0.18 % | $ 7.04 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 190.08 | 1.37 % | $ 9.42 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 468.18 | 0.18 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 4.31 | -0.58 % | $ 399 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 11.08 | -0.63 % | $ 1.42 B | ||
|
National Research Corporation
NRC
|
14.3 | $ 18.37 | -2.24 % | $ 411 M | ||
|
Natera
NTRA
|
-112 | $ 215.44 | 1.59 % | $ 29.5 B | ||
|
Pacific Biosciences of California
PACB
|
-2.24 | $ 1.39 | 5.73 % | $ 417 M | ||
|
Personalis
PSNL
|
-4.87 | $ 9.99 | 4.17 % | $ 892 M | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.73 | 1.0 % | $ 25.3 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 7.27 | 1.18 % | $ 303 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.01 | -1.95 % | $ 4.62 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 263.91 | -0.74 % | $ 22 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 80.85 | 6.14 % | $ 4.84 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 472.33 | 0.74 % | $ 178 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.66 | 1.0 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.1 | -0.05 % | $ 1.97 B | ||
|
Invitae Corporation
NVTA
|
44.6 | - | - | $ 21.2 M |